Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.
Mao T, Israelow B, Peña-Hernández MA, Suberi A, Zhou L, Luyten S, Reschke M, Dong H, Homer RJ, Saltzman WM, Iwasaki A. · 2022
Read Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. by Mao T, Israelow B, Peña-Hernández MA, Suberi A, Zhou L, Luyten S, Reschke M, Dong H, Homer RJ, Saltzman WM, Iwasaki A. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9798903.txt.
Description
Mao and co-authors test a nose spray spike booster that builds protective mucosal immunity in mice. Shots in the arm raise strong blood immunity against COVID-19. They leave the nose and airway lining weakly guarded. Virus spread keeps going through that unguarded front door.
Their plan pairs a standard first vaccine with a nasal boost. The boost is plain spike protein with no adjuvant added. It wakes memory cells that settle in the airway tissue. Antibody IgA rose at the breathing surfaces after the boost. Systemic immunity also gained strength from the pairing. Mice with partial immunity were fully shielded from lethal infection. Swapping in spikes from related viruses widened the cover. Cross-reactive immunity reached other sarbecoviruses in the tests. The authors pitch the scheme as a transmission blocker. It builds on immunity that shots already created.
Catalog record
| CREATOR | Mao T, Israelow B, Peña-Hernández MA, Suberi A, Zhou L, Luyten S, Reschke M, Dong H, Homer RJ, Saltzman WM, Iwasaki A. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |